These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 29137332)
1. Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression. Xiao Y; Yurievich UA; Yosypovych SV Oncotarget; 2017 Oct; 8(47):83171-83182. PubMed ID: 29137332 [TBL] [Abstract][Full Text] [Related]
2. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis. Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151 [TBL] [Abstract][Full Text] [Related]
3. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
4. lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer. Li P; Zhang X; Wang L; Du L; Yang Y; Liu T; Li C; Wang C Mol Ther Nucleic Acids; 2017 Sep; 8():356-369. PubMed ID: 28918035 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. Song H; He P; Shao T; Li Y; Li J; Zhang Y J BUON; 2017; 22(3):696-703. PubMed ID: 28730777 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells. Fan H; Zhu JH; Yao XQ Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells. Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025 [TBL] [Abstract][Full Text] [Related]
8. Role of genomic factors beyond thymidylate synthase in the prediction of response to 5-fluorouracil. Peters GJ; Smid K; Meijer E; van Groeningen CJ; Leon LG Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):595-603. PubMed ID: 27906628 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
10. Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury. Gu S; Xie R; Liu X; Shou J; Gu W; Che X Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368292 [TBL] [Abstract][Full Text] [Related]
11. Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: implications in the analysis of 5FU-acquired resistance mechanisms. Plasencia C; Rooney PH; Taron M; Martinez-Balibrea E; McLeod HL; Abad A Int J Oncol; 2003 May; 22(5):945-53. PubMed ID: 12684658 [TBL] [Abstract][Full Text] [Related]
12. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway. Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879 [TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718 [TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines. Plasencia C; Abad A; Martinez-Balibrea E; Taron M Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710 [TBL] [Abstract][Full Text] [Related]
15. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Tantai J; Hu D; Yang Y; Geng J Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353 [TBL] [Abstract][Full Text] [Related]
16. Suppression of TWIST1 enhances the sensitivity of colon cancer cells to 5-fluorouracil. Sakowicz-Burkiewicz M; Przybyla T; Wesserling M; Bielarczyk H; Maciejewska I; Pawelczyk T Int J Biochem Cell Biol; 2016 Sep; 78():268-278. PubMed ID: 27458056 [TBL] [Abstract][Full Text] [Related]
17. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway. Wang Y; Zhang M; Xu H; Wang Y; Li Z; Chang Y; Wang X; Fu X; Zhou Z; Yang S; Wang B; Shang Y Oncotarget; 2017 Sep; 8(42):72182-72196. PubMed ID: 29069778 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-330 inhibited cell proliferation and enhanced chemosensitivity to 5-fluorouracil in colorectal cancer by directly targeting thymidylate synthase. Xu W; Jiang H; Zhang F; Gao J; Hou J Oncol Lett; 2017 May; 13(5):3387-3394. PubMed ID: 28521444 [TBL] [Abstract][Full Text] [Related]
19. E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy. Sulzyc-Bielicka V; Domagala P; Bielicki D; Safranow K; Rogowski W; Domagala W Pathol Oncol Res; 2016 Jul; 22(3):601-8. PubMed ID: 26831819 [TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]